1.
BMJ Case Rep
; 16(10)2023 Oct 11.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37821144
RESUMEN
Aspergillosis is a challenging fungal infection. Voriconazole is an antifungal drug belonging to the triazole group, commonly used for treating invasive aspergillosis, Cryptococcus neoformans and candida infections. We present a case of a man in his late 70s diagnosed with rhino-orbital invasive aspergillosis who developed voriconazole-induced psychosis as an idiosyncratic, adverse drug reaction (ADR); however, he responded to the cessation of intravenous voriconazole and, after starting on an oral antipsychotic, haloperidol. Clinicians need to be cognizant of this rare, idiosyncratic and iatrogenic ADR to voriconazole.
Asunto(s)
Aspergilosis , Infecciones Fúngicas Invasoras , Trastornos Psicóticos , Masculino , Humanos , Voriconazol/efectos adversos , Pirimidinas/uso terapéutico , Aspergilosis/tratamiento farmacológico , Aspergilosis/microbiología , Antifúngicos/efectos adversos , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Trastornos Psicóticos/tratamiento farmacológico
2.
BMJ Case Rep
; 17(6)2024 Jun 05.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38839407